This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n4http://linked.opendata.cz/resource/drugbank/drug/DB03115/identifier/pubchem-substance/
n11http://linked.opendata.cz/resource/drugbank/drug/DB03115/identifier/drugbank/
n10http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n5http://linked.opendata.cz/ontology/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n7http://linked.opendata.cz/resource/drugbank/drug/DB03115/identifier/pdb/
n8http://linked.opendata.cz/resource/drugbank/drug/DB03115/identifier/pubchem-compound/

Statements

Subject Item
n2:DB03115
rdf:type
n5:Drug
n5:group
experimental
owl:sameAs
n10:DB03115 n12:DB03115
dcterms:title
5-Bromo-N-(2,3-Dihydroxypropoxy)-3,4-Difluoro-2-[(2-Fluoro-4-Iodophenyl)Amino]Benzamide
adms:identifier
n4:46505983 n7:BBM n8:17753852 n11:DB03115
n5:IUPAC-Name
n6:271B50A1-363D-11E5-9242-09173F13E4C5
n5:InChI
n6:271B50A7-363D-11E5-9242-09173F13E4C5
n5:Molecular-Formula
n6:271B50A6-363D-11E5-9242-09173F13E4C5
n5:Molecular-Weight
n6:271B50A3-363D-11E5-9242-09173F13E4C5
n5:Monoisotopic-Weight
n6:271B50A4-363D-11E5-9242-09173F13E4C5
n5:SMILES
n6:271B50A5-363D-11E5-9242-09173F13E4C5
n5:Water-Solubility
n6:271B509F-363D-11E5-9242-09173F13E4C5
n5:logP
n6:271B50A0-363D-11E5-9242-09173F13E4C5 n6:271B509D-363D-11E5-9242-09173F13E4C5
n5:logS
n6:271B509E-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Acceptor-Count
n6:271B50AD-363D-11E5-9242-09173F13E4C5
n5:H-Bond-Donor-Count
n6:271B50AE-363D-11E5-9242-09173F13E4C5
n5:InChIKey
n6:271B50A8-363D-11E5-9242-09173F13E4C5
n5:Polar-Surface-Area--PSA-
n6:271B50A9-363D-11E5-9242-09173F13E4C5
n5:Polarizability
n6:271B50AB-363D-11E5-9242-09173F13E4C5
n5:Refractivity
n6:271B50AA-363D-11E5-9242-09173F13E4C5
n5:Rotatable-Bond-Count
n6:271B50AC-363D-11E5-9242-09173F13E4C5
n5:Bioavailability
n6:271B50B3-363D-11E5-9242-09173F13E4C5
n5:Ghose-Filter
n6:271B50B5-363D-11E5-9242-09173F13E4C5
n5:MDDR-Like-Rule
n6:271B50B6-363D-11E5-9242-09173F13E4C5
n5:Number-of-Rings
n6:271B50B2-363D-11E5-9242-09173F13E4C5
n5:Physiological-Charge
n6:271B50B1-363D-11E5-9242-09173F13E4C5
n5:Rule-of-Five
n6:271B50B4-363D-11E5-9242-09173F13E4C5
n5:Traditional-IUPAC-Name
n6:271B50A2-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-acidic-
n6:271B50AF-363D-11E5-9242-09173F13E4C5
n5:pKa--strongest-basic-
n6:271B50B0-363D-11E5-9242-09173F13E4C5